Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Flexible Mechanoporation Chips for High-Throughput Intracellular Delivery Based on Controlled Pneumatic Microvalve Array.

Qu J., Wang S., Chen C., Zhang Y., Lai S., Gu R.

Animal Study on Hip, published in ACS Nano (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
ACS Nano (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40504890
DOI
10.1021/acsnano.5c01000
Citations
3

Abstract (original English)

Mechanoporation-based intracellular delivery has emerged as an effective technique for transporting materials into living cells through the application of mechanical loading and deformation. Although this technique holds significant potential for large-scale cell manufacturing without the need for additional carriers, there exist several challenges, including a high degree of size dependence, inconsistencies due to cellular heterogeneity, and the risk of channel clogging and cell damage. Here, we developed a flexible mechanoporation chip system that integrated a three-layer pneumatic microvalve array for high-throughput intracellular delivery. Both our simulation data and experimental results indicated that it could minimize cell damage and enhance delivery efficiency through volume exchange and molecular convection. The adaptive deformation design of the microvalve array allowed it to accommodate variations in the geometric sizes and mechanical properties of cell populations, thereby optimizing intracellular delivery. Furthermore, we demonstrated that the flexible mechanoporation chip system could effectively deliver various biomolecules, including drugs, mRNA, and plasmid DNA, into diverse cell types like mouse embryonic fibroblasts (MEFs), adipose-derived stem cells (ASCs), and primary T cells. This flexible mechanoporation chip platform presents a promising tool for efficie

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMiceDrug Delivery SystemsDNA

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research